0001746104-18-000003.txt : 20180712 0001746104-18-000003.hdr.sgml : 20180712 20180712154346 ACCESSION NUMBER: 0001746104-18-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180712 DATE AS OF CHANGE: 20180712 EFFECTIVENESS DATE: 20180712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Recida Therapeutics, Inc. CENTRAL INDEX KEY: 0001746104 IRS NUMBER: 812178106 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-316724 FILM NUMBER: 18950441 BUSINESS ADDRESS: STREET 1: 70 WILLOW ROAD STREET 2: SUITE 200 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-843-5214 MAIL ADDRESS: STREET 1: 70 WILLOW ROAD STREET 2: SUITE 200 CITY: MENLO PARK STATE: CA ZIP: 94025 D 1 primary_doc.xml X0708 D LIVE 0001746104 Recida Therapeutics, Inc. 70 WILLOW ROAD SUITE 200 MENLO PARK CA CALIFORNIA 94025 650-325-5156 DELAWARE North Bridge III, Inc. None Corporation true 2016 Yigong Ge c/o Recida Therapeutics, Inc. 70 Willow Road, Suite 200 Menlo Park CA CALIFORNIA 94025 Executive Officer Director David Socks c/o Recida Therapeutics, Inc. 70 Willow Road, Suite 200 Menlo Park CA CALIFORNIA 94025 Director Patrick Heron c/o Recida Therapeutics, Inc. 70 Willow Road, Suite 200 Menlo Park CA CALIFORNIA 94025 Director Michael Savino 213 West Institute Place Suite 301 Chicago IL ILLINOIS 60610 Executive Officer Biotechnology Decline to Disclose 06b false 2018-06-29 false true true Conversion of Notes false 0 10667877 5667877 5000000 false 1 0 0 0 false Recida Therapeutics, Inc. /s/ Yigong Ge Yigong Ge Chief Executive Officer 2018-07-12